Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Samsung Electronics Co. Ltd. 0.00% ₩356.7T ...

American Electric Power Co. Inc. 0.00% $52.22B ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Barron's reporters have screened for potentially attractive stocks based on a variety of metrics. Here are the stocks they have identified for investors to research further. Barron's reporters ...

Intel will report its Q4 earnings after the bell Thursday. Donald Trump's pick for commerce secretary underlined that big and broad tariffs are top of mind both for him and the president during his ...

Rights Apr 06, 2015-Jan 27, 2015 Rights ratio: 6 share for every 109 held at a price of Rs 450.0 Rights Apr 06, 2015-Jan 27, 2015 Rights ratio: 6 share for every 109 held at a price of Rs 271.0 Rights ...

Bonus Oct 28, 2024 Oct 28, 2024 Sep 05, 2024 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 13, 2020 May 14, 2020 Apr 30, 2020 Rights ratio: 1 share for every 15 held at a price of Rs 1257 ...

Rights Jan 31, 2018 Feb 01, 2018 Dec 20, 2017 Rights ratio: 2 share for every 25 held at a price of Rs 615.0 Rights Jan 31, 2018 Feb 01, 2018 Dec 19, 2017 Rights ratio: 4 share for every 25 held at a ...